Literature DB >> 20530412

Evidence of a tumour suppressor function for DLEC1 in human breast cancer.

W Al Sarakbi1, S Reefy, W G Jiang, T Roberts, R F Newbold, K Mokbel.   

Abstract

UNLABELLED: DLEC1 (deleted in lung and oesophageal cancer), located on 3p22.3, is a candidate tumour suppressor gene in lung, esophageal, and renal cancer. The aim of this study was determine whether the mRNA expression levels of DLEC1 were consistent with a tumour suppressive function.
MATERIALS AND METHODS: A total of 153 samples were analysed. The levels of transcription of DLEC1 were determined using quantitative PCR and normalised against (CK19). Transcript levels within breast cancer specimens were compared to normal background tissues.
RESULTS: Levels of transcription were lower [corrected] in tumour samples compared to adjacent non cancerous tissue (ANCT) samples but this was not statistically significant (median 0.167 vs. 0.03; p=0.138). DLEC1 expression levels were significantly lower in samples from patients who developed metastasis, local recurrence, or died of breast cancer when compared to those who were disease free for >10 years (p=0.041). DISCUSSION: These findings are consistent with a possible tumour suppressor function of DLEC1 in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530412

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.

Authors:  Lian Zhang; Qian Zhang; LiLi Li; Zhaohui Wang; Jianming Ying; Yu Fan; Qun He; Tianjing Lv; Wenke Han; Jun Li; Yang Yang; Ben Xu; Lu Wang; Qianling Liu; Yinghao Sun; Yinglu Guo; Qian Tao; Jie Jin
Journal:  J Mol Med (Berl)       Date:  2015-02-05       Impact factor: 4.599

2.  Methylation of DLEC1 promoter is a predictor for recurrence in Chinese patients with gastric cancer.

Authors:  Xiaobing Ye; Gang Feng; Nanlin Jiao; Chun Pu; Guohai Zhao; Guoping Sun
Journal:  Dis Markers       Date:  2014-12-09       Impact factor: 3.434

3.  Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.

Authors:  Lili Li; Juan Xu; Guohua Qiu; Jianming Ying; Zhenfang Du; Tingxiu Xiang; Kai Yau Wong; Gopesh Srivastava; Xiao-Feng Zhu; Tony S Mok; Anthony Tc Chan; Francis Kl Chan; Richard F Ambinder; Qian Tao
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

4.  Identification of DLEC1 D215N Somatic Mutation in Formalin Fixed Paraffin Embedded Melanoma and Melanocytic Nevi Specimens.

Authors:  Ricardo Vieira; Maria José Simões; Susana Carmona; Conceição Egas; Carlos Faro; Américo Figueiredo
Journal:  J Skin Cancer       Date:  2013-10-13

Review 5.  Central Apparatus, the Molecular Kickstarter of Ciliary and Flagellar Nanomachines.

Authors:  Zuzanna Samsel; Justyna Sekretarska; Anna Osinka; Dorota Wloga; Ewa Joachimiak
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.